The enhancement of Nrf2 transcription with sulforaphane or melatonin could benefit patients with LONG COVID (Post-Acute Sequelae of SARS-CoV-2 or Post-COVID-Syndrome), a significant proportion (approximately 40%) of individuals with COVID-19 experiencing a variety of symptoms (loss of smell and/or taste, fatigue, cough, aching pain, brain fog, insomnia, shortness of breath, and tachycardia) after 12 weeks (Jarrott et al., 2022
Treatment recommendations vary based on provider evaluation and individual goals
Ikhlas S, Ahmad M (2017) Metformin: insights into its anticancer potential with special reference to AMPK dependent and independent pathways
Sharma A, Sharma T, Bhaskar R, Ola M, Sharma A, Sharma PC
Dr Shira Lakhani is the women for this job